Agoracom Blog Home

Author Archive

VIDEO – Victory Square Technologies $VST $VSQTF Eyes Web 3.0 Future via Blockchain, NFTs, Creator Economy & More

Posted by AGORACOM-AB at 12:00 PM on Monday, December 20th, 2021
Victory Square Technologies VST

Victory Square Technologies Inc. (CSE:VST) (OTC:VSQTF) (FWB:6F6) provides investors access to a diverse portfolio of next generation technology companies in key sectors, including: Web 3.0BlockchainGaming, the Creator EconomyNFTs and the Metaverse.

“We are living in the midst of the 4th Industrial Revolution; The Tech Revolution that will undoubtedly change everything as we know it,” says VST CEO Shafin Diamond Tejani

“Web 3.0, Blockchain, Gaming, VR/AR, the Creator Economy, Digital Health and Climate Tech are all sectors that Victory Square has invested in. We offer investors the chance to invest in the most exciting tech trends all in one place with a uniquely liquid, audited and secure way to gain access to these latest innovative technologies.”

Across the next 120 days, VST’s primary goals will be to:

  • Issue The Second Tranche Of a Special Common Share Dividend of its Interest in Portfolio Company Fantasy 360 Technologies Inc. (dba Immersive Tech)
  • Assist Stardust Solar Technologies Inc., Turnium Technology Group Inc., Cassia Research Inc. (doing business as CoPilot.AI) and Shop and Shout Ltd. (doing business as with considering and preparing for potential public listing transactions.
  • Ramp up sales and marketing to provide Victory Square Digital Health’s full-suite of mobile digital health solutions and telemedicine platform to surgery centres, skilled nurses, home care agencies and hospice care.
  • Work with Victory Square Health to grow the Company’s roster of diagnostic tests and expand its digital health business within Brazil, the U.S. and Canada.
  • Work with to complete the development of an add-on feature which will allow creators to launch their own digital currency powered by the blockchain.
  • Successfully incubate next batch of VST projects working on the following: Exchange Traded Protocols (Metaverse, DeFi, GameFi, DAOs), P2E (Play to Earn) Games, Decentralized Social Networks (DeSo Creator Platform).

Against this backdrop, Agoracom founder George Tsiolis sat down with the CEO to discuss the shape of the future…

A Message From GameOn $GET CEO Matt Bailey re: Times Internet & Polygon

Posted by AGORACOM-AB at 11:53 AM on Monday, December 6th, 2021

Shareholders & friends,

Off the back of announcing our deals with Times Internet and Polygon ($MATIC), I wanted to end the week with a personal note. This week was a watershed moment for GameOn. A moment when a small, relatively unknown CA$20 million market cap company became backed by India’s largest media conglomerate and a leading blockchain with a US$22 billion market cap. This is strong validation of the mission, products and team that fuel our business each day. 

While many don’t know who we are yet, that’s now shifting. Just yesterday, we were written up by VentureBeat, a tech news leader that receives 12 million monthly views and is regularly read by Mark Zuckerberg. I was also recently featured in Forbes. Both customers and investors are being awoken by the noise we’re making, and they’re starting to take note.

While the market has been choppy, we’ve quietly had our heads down building and closing deals. 2022 is set up to be the year of scaling customers and revenue. If you’ve followed us since listing, you’ll know we execute on what we say we will. We expect the next 12-24 months to be no different. The first inning is over. Batter up for the second, now with the likes of Times Internet and Polygon on-deck.

Look out for a more detailed corporate update next week. In the meantime, thank you for the ongoing support. Have a great weekend! 


Polygon Studios Invests in GameOn, Strategically Partners to Bring NFT Games to the Masses
GameOn Secures Up to US$6 Million in Strategic Investment from India’s Brand Capital International

VIDEO – AI/ML Innovations $AIML $AIMLF set to Make Waves w/ Health Gauge Partnership, U.S. Launch for AI Rx $ $ $

Posted by AGORACOM-AB at 3:09 PM on Tuesday, October 26th, 2021
AI/ML Innovations Inc.

AI/ML Innovations is capitalizing on the burgeoning areas of artificial intelligence (AI), cloud computing and machine learning (ML), with an initial focus on emerging companies in the digital healthcare space.

Its key subsidiary, Health Gauge, is a leading digital health solutions provider that’s disrupting the traditional healthcare industry by providing AI innovations and services that improve health outcomes, while at the same time reducing costs and stresses on the overburdened healthcare infrastructure.

Its patent-pending solution is a bespoke personal health monitoring and management system, combining the latest wearable health monitors with sophisticated software tools.

Health Gauge provides for a secure and trusted means for clients to engage clinical resources and health coaching as a regular part of their care process and ongoing health management. Its robust, real-time data capture capability provides fast feedback, resulting in better recovery outcomes and healthy living objectives through the ability to make immediate and better health choices.

In addition to Health Gauge, AI/ML also has a strategic partner in Tech2Heal, a France-based global provider of proprietary digital mental health and wellness products.

In late September, AI/ML announced that it had completed its transaction to acquire a significant interest in Tech2Heal (dba Tech2Health), and that Tech2Heal was readying its remote patient monitoring platform for deployment.

Now, AI/ML Innovations & Tech2Heal’s AI Rx joint venture is preparing for imminent launch into the U.S. market, with a basket of wellness and health-tech products and services designed to improve an individual’s mental health and well-being, and utilizing a unique blend of proprietary digital assets, remote live counselling, and a physical wellness center.

We caught up with Tim Daniels, AI/ML’s Executive Chairman, to discuss the firm’s progress…

VIDEO – TAAT Global Alternatives $TAAT $TOBAF “Beyond Tobacco” Eyes $10m Investment Boost, Preps Branded Apparel for Q1 2022 $MO $PM $BATS

Posted by AGORACOM-AB at 9:23 AM on Monday, October 18th, 2021

To understand the value proposition of TAAT, you first have to understand some recent massive trends in the Consumer Packaged Goods (CPG) space:

  • Non-alcoholic beer has grown to an $18bn USD market
  • The plant-based meat market is projected to hit $74bn USD By 2027

What they have in common is providing consumers of the original products with the exact same experience (taste, smell, etc.) without the negative parts of the original products.

TAAT has developed a nicotine-free and tobacco-free smoking experience known as TAAT™, which already launched in the USA. TAAT™ Beyond Tobacco™ cigarettes mimic those experiences without nicotine or tobacco.

Engineered to closely emulate the sensory components to provide the closest experience of smoking a tobacco cigarette – a product that tastes and smells just like tobacco – but without the nicotine.

October has seen a flurry of news for the company: 

OCT 5: The company reported Q3 2021 Financial Results:

1. Gross revenue grew to an all-time high of $1,305,358 in Q3 2021, an increase of 1,956% YOY
2. Gross profit for Q3 2021 was $781,226 with a gross profit margin of 59.84%
3. Healthy balance sheet with $10,174,001 in working capital

OCT 6: TAAT Announced it Would Be Releasing A Branded Merchandise Line of Apparel and Accessories in Q1 2022

OCT 13: TAAT Announced A Follow-On Private Placement for CAD $10m

We sat down with CEO Setti Coscarella for a company update…

VIDEO – Delic Corp $DELC $DELCF Aims to Become “Largest Psychedelic Wellness Chain in the U.S.” via Ketamine Wellness Centers Acquisition $CMPS $ALID

Posted by AGORACOM-AB at 1:43 PM on Friday, September 24th, 2021

How much is the market for psychedelics going to be worth?

According to one report published earlier this year by Data Bridge Market Research, it will reach $6.9 billion by 2027. Another report, from Research and Markets, predicts it will go further, reaching $10.75 billion by 2027.

In addition: California legislators are considering decriminalizing possession and sharing of psychedelics for adults 21 and older.

That’s the market context you need to know for Delic Corp, which bills itself as a marketplace for the mainstream to access psychedelic wellness.

Delic owns and operates an umbrella of related businesses, including trusted media and e-commerce platforms, including:

  • Delic Labs, the only licensed entity by Health Canada to exclusively focus on research and development of psilocybin vaporization technology
  • MeetDelic, the premiere psychedelic wellness event, which takes place in Las Vegas this year in November
  • and Ketamine Infusion Centers, one of the largest ketamine clinics in the United States

In May, Delic acquired Complex Biotech Discovery Ventures (CBDV), a federally-authorized psilocybin and cannabis research laboratory focused on extraction, analytical testing, and chemical process development, for $7m USD, changing its name to Delic Labs.

In June, Delic paid $3m USD to acquire Ketamine Infusion Centers, a limited liability corporation formed under the laws of Arizona, which owns and operates ketamine infusion treatment clinics in Phoenix, Arizona and in Bakersfield, California.

And now, Delic has this month entered into a binding merger with Ketamine Wellness Centers (KWC) Arizona, which operates 10 ketamine infusion treatment clinics across the U.S., in Arizona, Colorado, Florida, Illinois, Minnesota, Nevada Texas and Washington.

The deal and the national presence will bring psychedelic wellness treatment to the masses, and makes Delic the largest psychedelic wellness chain in the United States.

  • Retail Footprint to Include 12 Open Locations, with 15 Additional Clinics in Development
  • Ensures Accessibility to Millions with Affordable Treatments and Insurance Coverage
  • KWC has been operating profitably and expanding significantly with 2020 revenues in excess of $3.5m USD, on track for $4.5m USD in 2021
  • Joining Ketamine Infusion Centers (acquired June, 2021), which has grown steadily with revenues in excess of $4.2m USD since 2019

We sat down with Matt Stang, Delic’s CEO, to delve further into the acquisition…

VIDEO – GameOn Entertainment Technologies $GET $GMETF Preps for Big Q4 w/ Cricket Partnerships, NFL Survivor Pool

Posted by AGORACOM-AB at 10:47 AM on Thursday, September 9th, 2021

GameOn Entertainment Technologies (CSE: GET) (OTC: GMETF) powers the best content in the world with the most innovative predictive gaming technologies by providing broadcasters, TV networks, OTT platforms, leagues, tournaments and sportsbooks with interactive, social experiences around sports, television and live events.

The company lets fans connect, make predictions, track live scores and be rewarded during every moment of their favorite sports, TV shows and live events, offering a solution for the future of superfan engagement.

Two of the firm’s most recent deals have made waves in the world of international cricket. After securing Indian giant MX Player as a partner in June, GameOn this month struck a deal with North American cricket coverage provider Willow TV.

The free-to-play games will be available to MX Player and Willow TV’s large and diverse fan bases for global cricket events, tournaments and leagues, and both products will go live to more than 280 million monthly viewers in October, in time for the ICC T20 World Cup.  

The partnerships are just two initiatives ahead of what is expected to be a major Q4. GameOn has also launched an NFL Shareholder Survivor Pool tournament, which is free to play for shareholders, partners and friends of the business.

Throughout the contest, competitors will learn more about the people behind the company, with prizes including rare NFTs and an all-inclusive trip to an NFL game with GameOn CEO Matt Bailey.

Partners can sign up here:

Off the back of a strong week of trading, we sat down for a conversation with the chief executive – you won’t want to miss it!

VIDEO – TAAT Global Alternatives $TAAT $TOBAF “Beyond Tobacco” Offering Faces Rapid U.S., Int’l Expansion, After Strong Q2 Numbers $MO $PM $BATS

Posted by AGORACOM-AB at 3:49 PM on Friday, September 3rd, 2021

To understand the value proposition of TAAT, you first have to understand some recent massive trends in the Consumer Packaged Goods (CPG) space:

  • Non-alcoholic beer has grown to $18bn USD market
  • the plant-based meat market is projected to hit $74bn USD By 2027

What they have in common is providing consumers of the original products with the exact same experience (taste, smell, etc.) without the negative parts of the original products.

TAAT has developed a nicotine-free and tobacco-free smoking experience known as TAAT™, which already launched in the USA. TAAT™ Beyond Tobacco™ cigarettes mimic those experiences without nicotine or tobacco.

Engineered to closely emulate the sensory components to provide the closest experience of smoking a tobacco cigarette – a product that tastes and smells just like tobacco – but without the nicotine.

Last week the company passed two major milestones:

  • On August 25, TAAT announced that a Michigan tobacco chain would be placing TAAT in all 147 of its store locations
  • Two days later, TAAT announced that it had secured distribution on its third continent, with a purchase order for €360,000 (approximately $536,000 CAD) for a full shipping container of TAAT™ to be distributed in Australia

We sat down with CEO Setti Coscarella to break down the company’s rapid expansion, and examine what comes next…

VIDEO – Victory Square Technologies $VST $VSQTF Sees Record 6th Consecutive Quarter of Positive Net Income, Eyes Dividends, Tokens & Growth Industries $ $ $

Posted by AGORACOM-AB at 1:28 PM on Friday, September 3rd, 2021
Victory Square Technologies VST

Victory Square Technologies (VST:CSE / VSQTF:OTC / 6F6:FWB) builds, acquires and invests in promising start-ups, then provides the senior leadership and resources needed for fast-track growth.

Across its portfolio of 24 global companies, it covers A.I., Virtual Reality / Augmented Reality, Blockchain, Fintech, Health-tech, Gaming, Sports Betting and SaaS.

And the success its portfolio has achieved – by way of firms such as GameOn Entertainment TechnologiesHydreight and Immersive Tech – has led to a record sixth consecutive quarter with positive net income and earnings per share:

  • The firm reported record net income of $19,733,031 and positive Earnings Per Share of $0.30 in Fiscal 2020
  • During the six months ending June 30, 2021, the adjusted net income of the Company was $7,653,255
  • During the three months ending June 30, 2021, the adjusted net income of the Company was $2,222,180
  • VST Issued a special dividend of common shares of its portfolio company GameOn Entertainment Technologies (GET: CSE) in May 2021
  • Followed by a special dividend of common shares of its portfolio company Fantasy 360 Technologies Inc. (CSE (reserved):VRAR) aka Immersive Tech in August

We sat down with Shafin Diamond Tejani, Victory Square’s CEO, to break down the numbers and look ahead to the future…

VIDEO – VSBLTY Groupe Technologies $VSBY $VSBGF Rides “Deployment Momentum” to Strong Q2, w/ 165% Growth & $4.1m in New Sales $AT $MARK

Posted by AGORACOM-AB at 10:24 AM on Thursday, August 26th, 2021

VSBLTY Groupe Technologies (CSE:VSBY / OTC:VSBGF) is a disruptive computer vision software company that is using A.I. and Machine Learning to transform the retail and security industries.

  • $VSBY Teaches Computers How to Interpret Surroundings. For example, detecting anomalies better than any human ever can
  • $VSBY Then Delivers the Context of Their Surroundings via Alerts, so that humans can make decisions and act on then faster than ever possible
  • $VSBY technology serves the dual function of both monitoring (i.e. a stadium, a store) and marketing (serving ads based on real-time demographics)

In March, the company signed a major deal with Grupo Modelo (part of the AB InBev family of companies) and Retailigent to jointly create an international digital in-store media network.

And in June, VSBLTY raised $9.78 million in funding, putting the company on a path to profitability.

Now, VSBLTY CEO Jay Hutton has provided a corporate update, detailing that:

  • Q2 yielded strong billings growth, at 165% over Q1
  • A total of $4.1 million USD in new contracts
  • And accelerated growth, as the company gains “deployment momentum.”

We sat down with the chief executive, for a deeper dive into the state of play…

VIDEO – Cardiol Therapeutics $CRDL Sees Accelerated Growth with NASDAQ Uplisting & Continued COVID-19 Threat $LXRX $MESO $HGEN $TYNA

Posted by AGORACOM-AB at 12:15 PM on Monday, August 16th, 2021

Biotech companies, by their very nature, can often be difficult to understand for investors… but in order to understand Cardiol, all you have to know is that the firm is developing therapies for heart disease and heart failure through cannabidiols.  

Cardiol Therapeutics is a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease (heart/blood vessels).

  • The company has received approval from the U.S. FDA to commence a Phase II/III, double-blind, placebo-controlled clinical trial investigating the efficacy and safety of its lead clinical product, CardiolRx™.
  • CardiolRx™ is an ultra-pure, high concentration cannabidiol oral formulation that is pharmaceutically producedmanufactured under cGMP and THC free. (less than 10 ppm)

Cardiol is also planning a Phase II international trial of CardiolRx™ in acute myocarditis, a condition caused by inflammation in heart tissue, most common cause of sudden cardiac death in people under 35.

This week, the company passed another major milestone, moving from the OTC Markets to a U.S. listing on NASDAQ, under the symbol $CRDL – the same as its TSX symbol.

And with the COVID-19 Delta Variant running rampant through North America, Cardiol’s work has become more important than ever.

We sat down with David Elsley, Cardiol Therapeutics’ President & CEO, to discuss the uplisting…